Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML

We have recently reported that poly-SUMO-2/3 conjugates are subject to a ubiquitin-dependent proteolytic control in human cells. Here we show that arsenic trioxide (ATO) increases SUMO-2/3 modification of promyelocytic leukemia (PML) leading to its subsequent ubiquitylation in vivo. The SUMO-binding...

Full description

Saved in:
Bibliographic Details
Published inFEBS letters Vol. 582; no. 21; pp. 3174 - 3178
Main Authors Weisshaar, Stefan R., Keusekotten, Kirstin, Krause, Anke, Horst, Christiane, Springer, Helen M., Göttsche, Kerstin, Dohmen, R. Jürgen, Praefcke, Gerrit J.K.
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 22.09.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have recently reported that poly-SUMO-2/3 conjugates are subject to a ubiquitin-dependent proteolytic control in human cells. Here we show that arsenic trioxide (ATO) increases SUMO-2/3 modification of promyelocytic leukemia (PML) leading to its subsequent ubiquitylation in vivo. The SUMO-binding ubiquitin ligase RNF4 mediates this modification and causes disruption of PML nuclear bodies upon treatment with ATO. Reconstitution of SUMO-dependent ubiquitylation of PML by RNF4 in vitro and in a yeast trans vivo system revealed a preference of RNF4 for chain forming SUMOs. Polysumoylation of PML in response to ATO thus leads to its recognition and ubiquitylation by RNF4.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-5793
1873-3468
DOI:10.1016/j.febslet.2008.08.008